AGPU Axe Compute Inc. logo

AGPU Axe Compute Inc.

Technology
$6.46+0.00%OpenMarket Cap: $21.9M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

PEG

P/B

2.81

P/S

360.37

EV/EBITDA

-0.12

DCF Value

$0.42

FCF Yield

-68.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

-325.2%

Operating Margin

-58805.9%

Net Margin

-474020.6%

ROE

-10705.2%

ROA

-527.1%

ROIC

-70.9%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$35.3K$-7.7M$
Q4 null$8.7K$-150.9M$
FY null$125.3K$-233.1M$
Q3 null$3.6K$-77.7M$

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
Zhu Theodoredirector
SellFri May 01
Zhu Theodoredirector:
SellFri May 01
Rao Veenadirector
SellThu Apr 23
Nuzum Charles Lee Srdirector
SellThu Apr 23
Matthews Shawndirector
SellThu Apr 23

Company Info

Sector

Technology

Industry

Software - Infrastructure

Country

US

Exchange

Beta

3.47

Axe Compute Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. Predictive Oncology Inc. has a strategic collaboration with Every Cure to identify and prioritize drugs for repurposing. The company was formerly known as Predictive Oncology Inc. and changed its name to Axe Compute Inc. in December 2025. Axe Compute Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.

Peers